European Journal of Molecular & Clinical Medicine

Abstract

The present study involved 100 patients experiencing little bowel impediment with a background marked by past stomach medical procedure. Patients with supported deterrent who grew clinically or radiologically in the initial 24 hours kept on accepting traditionalist treatment. Conservative therapy was declared to fail in patients that reported no radiological or clinical improvement within 24 hours. After primary treatment of gastrografin and conservative treatment in study groups the obstruction was relieved in 44 (88%) patients of gastrografin group. To conclude, Gastrografin is safe and it can be used therapeutically in resolution of ASBO. It decreases necessity of surgery when conservative procedure fails.